Abstract
Stenting of small vessels might be associated with higher rates of adverse events. The relationship between stent strut thickness and adverse clinical events remains particularly evident in smaller vessels. Recently published trial showed biolimus A9-eluting stent (BES) was non-inferior with
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
